Posted on 04/29/2015 in Blog Post, GC
Q: I have a healthy diet, no history of heart disease in my family, and I am overweight but not obese—do I really need to exercise?
Mandy Kenyon, MS, RD, CSSD, is Pathway Genomics’ Registered Dietitian and played a major role in developing the customized diet plans that are part of tests such as Pathway Fit. Mandy is available to answer nutrition- and diet-related questions for Pathway’s clients and customers—contact her at firstname.lastname@example.org.
Mandy recently shared a couple of the most common questions she receives in her work as a dietitian, as well as her responses:
Absolutely. Being overweight (a BMI of 25.0–29.9) can have consequences, such as an increased risk of coronary heart disease, high blood pressure, stroke, and type II diabetes. Exercise can reduce these risks, and may improve both your current and future health by lessening the chance of complications later on.
If you didn’t start exercising, let’s imagine the worst-case scenario: You would maintain your weight eating the same amount of calories. As you aged, your biological processes would slow. Maybe you would need pain medication for arthritis from the stress extra weight puts on your joints. Your doctor might even find that you have type II diabetes and metabolic syndrome, a group of risk factors that predisposes you to other conditions like cancer and heart disease. One day before you inject your insulin and prepare your dietitian-approved breakfast (but after you take your blood pressure medication, diuretic, ACE inhibitor, daily diabetic drug, osteoarthritis medication, and pain medication), you decide to sign up for weight-loss surgery. The first requirement for surgery states: Must exercise 5 times a week.
The lesson? The need to exercise catches up with everyone eventually, so starting while you are relatively healthy will benefit you the most. A great place to start is the American Heart Association’s exercise guidelines—
30 minutes of moderate-intensity aerobic activity 5 times per week with weight-training at moderate- to high-intensity twice a week.
Keep in mind that anything is always better than nothing. If you can only get in 15 minutes here or there, do it anyway! If you are short on time, increase your intensity. Or you can increase the duration. Exercise is just physical activity; it doesn’t have to be a typical gym or aerobics class. Make it fun so you look forward to doing it rather than feeling that you absolutely have to.
Posted on 03/11/2015 in News, Press Releases
San Diego, CA – March 11, 2015
– Pathway Genomics Corporation, a forward-thinking big data healthcare company and global precision medicine clinical laboratory, has announced that endocrinologist Dr. Glenn D. Braunstein is the company’s new Chief Medical Officer. Dr. Braunstein takes on the role after serving on Pathway Genomics’ Strategic Advisory Board. With a special interest in pharmacogenomics, Dr. Braunstein’s first priority will be Pathway Genomics’ pharmacogenomic testing menu.
Posted on 03/10/2015 in Blog Post, Editorial
By Michael Nova, M.D.
Chief Innovation Officer
There has recently (2013-15) been a flurry of human clinical trial publications regarding gene-diet interactions, primarily concerning obesity and related phenotypes.
A new finding by the Genetic Investigation of Anthropometric Traits, or GIANT, consortium has identified 97 gene regions associated with obesity, tripling the number of such genes previously known.
Posted on 02/26/2015 in News, Press Releases
SAN DIEGO, CA
– February 26, 2015
– Pathway Genomics Corporation
, a CLIA and CAP accredited clinical laboratory that offers genetic testing services globally, announced that former Speaker of the U.S. House of Representatives Newt Gingrich has joined its strategic advisory board. A former candidate for president of the United States in 2012, Gingrich has spent more than four decades as a leader in American public life. During his time in Congress, he helped save Medicare from bankruptcy, shepherded FDA reform to help the seriously ill and initiated a new focus on scientific research, prevention and wellness.
Posted on 02/19/2015 in News, Press Releases
SAN DIEGO, CA
– February 19, 2015
– Pathway Genomics Corporation, a CLIA and CAP accredited clinical laboratory that offers genetic testing services globally, announced it has named Anja Kammesheidt, Ph.D., as its vice president of research and development. Based at Pathway Genomics’ San Diego headquarters, Dr. Kammesheidt brings more than 15 years of experience to the role.
“We are honored to have Dr. Kammesheidt join our organization where she will oversee all assay development activities,” said Jim Plante, Pathway Genomics’ founder and CEO. “We know that her wealth of knowledge will be a major asset to the company and a vital component of reaching our commercial objectives as we move forward.”
Posted on 02/10/2015 in News, Press Releases
SAN DIEGO, CA – February 10, 2015 – Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services globally, announced that Jacquelyn Powers, M.S., LCGC, of the Hospital of the University of Pennsylvania, and Ofri Leitner, M.S., CGC, of the University of North Carolina at Chapel Hill, have joined Pathway Genomics’ strategic advisory board. Powers and Leitner are well-respected clinical genetic counselors that are intimately involved in the hereditary cancer programs at their respective institutions.
Posted on 02/06/2015 in Blog Post, Editorial, News
By Corine K. Lau, Ph.D., and Jane Z. Kuo, M.D., Ph.D.
What does this mean for you and me?
Posted on 02/03/2015 in News, Press Releases
SAN DIEGO, CA
– February 3, 2015
– Pathway Genomics Corporation
, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services globally, announced today that Julie Neidich, M.D., FACMG, FAAP, has joined our team as the laboratory medical director. Dr. Neidich comes to Pathway Genomics from GeneDx where she was the clinical director of the Whole Exome Sequencing Program.
“Dr. Neidich has many years of experience in all aspects of genetic medicine and diagnostics, and she is a tremendous addition to our medical and science team,” said Jim Plante, Pathway Genomics’ founder and CEO.
Posted on 01/23/2015 in Blog Post, News, Press Releases
SAN DIEGO, Calif., Jan. 23, 2015 – Pathway Genomics Corporation (“Pathway”) today announced a settlement agreement that ends the BRCA patent litigation against Pathway that began on June 13, 2014.
Under the agreement, Myriad Genetics, Inc., the University of Utah Research Foundation, HSC Research and Development Limited Partnership, Endorecherche, Inc., and the Trustees of the University of Pennsylvania (the “Patent Owners”) and Pathway dismiss their respective claims and counterclaims against one another in the BRCA patent litigation. Additionally, the Patent Owners granted a covenant to not sue Pathway under the patents asserted in the litigation proceedings.
Posted on 12/11/2014 in News, Press Releases
SAN DIEGO, CA – December 11, 2014 – Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services globally, announced that former U.S. Representative and Secretary of Agriculture Dan Glickman joined its strategic advisory board.
“We’re honored to have Secretary Glickman as part of our advisory board,” said Jim Plante, Pathway Genomics’ founder and CEO. “In his 25 years in public service in Congress and as an advisor to the President as Cabinet Member, Dan Glickman distinguished himself as a solutions-oriented leader with impeccable integrity. His many accomplishments over that time speak for themselves, and we are extremely fortunate to now benefit from his vast experience.”